Deficiencies in AIM2 result in pathological RPE-EMT, which is consistent with EMT observed in hepatocellular or colorectal carcinoma cells in AIM2-deficient patients [42, 44]. The gene discussed is AIM2; the disease is colorectal carcinoma.